Evolent Health (EVH) Net Cash Flow (2015 - 2026)

Evolent Health has reported Net Cash Flow for 12 years, with the latest figure at -$11.4 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 111.44% year-over-year to -$11.4 million; the trailing twelve-month figure through Mar 2026 stood at -$108.0 million (down 342.51% YoY), and the FY2025 full-year result was $2.7 million, up 106.0% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$11.4 million, down from $37.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $99.3 million in Q1 2025, with the low at -$99.8 million in Q2 2025.
• Average Net Cash Flow over 5 years is -$10.8 million, with a median of -$1.0 million recorded in 2023.
• Peak annual rise in Net Cash Flow reached 5063.93% in 2024, while the deepest fall reached 711.04% in 2024.
• Tracing EVH's Net Cash Flow over 5 years: stood at $20.4 million in 2022, then slumped by 105.02% to -$1.0 million in 2023, then jumped by 5063.93% to $50.8 million in 2024, then retreated by 25.33% to $37.9 million in 2025, then tumbled by 129.97% to -$11.4 million in 2026.
• The last three Net Cash Flow figures came in at -$11.4 million (Q1 2026), $37.9 million (Q4 2025), and -$34.8 million (Q3 2025), per Business Quant data.

Peer Comparison